Metronidazole/clay nanocomposites: Synthesis, structure and antibacterial efficacy
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989100%3A27640%2F21%3A10246533" target="_blank" >RIV/61989100:27640/21:10246533 - isvavai.cz</a>
Výsledek na webu
<a href="https://www.sciencedirect.com/science/article/pii/S2214785320308476?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S2214785320308476?via%3Dihub</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.matpr.2020.02.101" target="_blank" >10.1016/j.matpr.2020.02.101</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Metronidazole/clay nanocomposites: Synthesis, structure and antibacterial efficacy
Popis výsledku v původním jazyce
Clays are materials commonly used in the pharmaceutical industry, either as excipients or as active substances. It was observed that when they are administered concurrently, they may interact with drugs reducing their absorption. Such interactions can be used to achieve technological and biopharmaceutical advantages, regarding the control of release. Interactions between clay minerals and drugs may be biopharmaceutically beneficial to improve solubility and/or change drug release profile. This study is focused on the preparation and characterization of organoclay vermiculite and/or bentonite) nanocomposite materials based on imidazole derivative metronidazole, which is antibiotic drug used predominantly for treatment of intestinal and periodontal diseases. The structure of prepared samples was characterized by the X-ray diffractometry (XRD) and infrared spectroscopy (FTIR). Furthermore, the content of organic carbon was determined in the nanocomposite samples by multiphase carbon and hydrogen/ moisture analyzer. Antimicrobial activity of nanocomposites was tested against bacterial strains S. aureus, E. faecalis, P. aeruginosa and E. coli, and it was evaluated by finding minimum inhibitory concentration (MIC). It was found that antibacterial activity depends on pH and also on clay matrix.
Název v anglickém jazyce
Metronidazole/clay nanocomposites: Synthesis, structure and antibacterial efficacy
Popis výsledku anglicky
Clays are materials commonly used in the pharmaceutical industry, either as excipients or as active substances. It was observed that when they are administered concurrently, they may interact with drugs reducing their absorption. Such interactions can be used to achieve technological and biopharmaceutical advantages, regarding the control of release. Interactions between clay minerals and drugs may be biopharmaceutically beneficial to improve solubility and/or change drug release profile. This study is focused on the preparation and characterization of organoclay vermiculite and/or bentonite) nanocomposite materials based on imidazole derivative metronidazole, which is antibiotic drug used predominantly for treatment of intestinal and periodontal diseases. The structure of prepared samples was characterized by the X-ray diffractometry (XRD) and infrared spectroscopy (FTIR). Furthermore, the content of organic carbon was determined in the nanocomposite samples by multiphase carbon and hydrogen/ moisture analyzer. Antimicrobial activity of nanocomposites was tested against bacterial strains S. aureus, E. faecalis, P. aeruginosa and E. coli, and it was evaluated by finding minimum inhibitory concentration (MIC). It was found that antibacterial activity depends on pH and also on clay matrix.
Klasifikace
Druh
D - Stať ve sborníku
CEP obor
—
OECD FORD obor
21001 - Nano-materials (production and properties)
Návaznosti výsledku
Projekt
—
Návaznosti
S - Specificky vyzkum na vysokych skolach
Ostatní
Rok uplatnění
2021
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název statě ve sborníku
Materials Today: Proceedings. Volume 37, Part 1
ISBN
—
ISSN
2214-7853
e-ISSN
2214-7853
Počet stran výsledku
7
Strana od-do
21-27
Název nakladatele
Elsevier
Místo vydání
Londýn
Místo konání akce
Ostrava
Datum konání akce
13. 5. 2019
Typ akce podle státní příslušnosti
WRD - Celosvětová akce
Kód UT WoS článku
000614126700004